EMR:
Right to market or controversy?
India’s first exclusive marketing right for a pharma
product, Glivec, granted to Swiss pharmaceutical giant,
Novartis has made news for all the wrong reasons.
Evaluation
of drugs for allergenicity
Certain approaches like serologic, enzymatic and genetic
analysis, using univalent or multivalent analysis may
help in containing drug allergy
